Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Sales | 517 | 281 | 230 | 140 | 318 |
Gross Profit | 517 | 281 | 230 | 140 | 318 |
Operating Expenses | 2,329 | 4,058 | 1,721 | 1,804 | 1,443 |
Operating Income | -1,812 | -3,777 | -1,491 | -1,664 | -1,125 |
Interest Expense | 598 | 641 | 664 | 935 | 219 |
Pre-tax Income | -2,410 | -4,417 | -2,155 | -2,599 | -1,344 |
Net Income Continuous | -2,410 | -4,417 | -2,155 | -2,599 | -1,344 |
Net Income | $-2,410 | $-4,417 | $-2,155 | $-2,599 | $-1,344 |
EPS Basic Total Ops | 0.00 | -479.04 | -479.04 | -479.04 | 0.00 |
EPS Basic Continuous Ops | -235.47 | -504.73 | -293.31 | -354.26 | -184.41 |
EPS Diluted Total Ops | 0.00 | -479.04 | -479.04 | -479.04 | 0.00 |
EPS Diluted Continuous Ops | -235.47 | -504.73 | -293.31 | -354.26 | -184.41 |
EBITDA(a) | $-1,124 | $-3,011 | $-565 | $-467 | $-690 |